Metabolic interactions can be identified through in vitro studies, clinical trials, and pharmacokinetic modeling. These approaches help predict interactions by examining enzyme activity, drug concentrations, and metabolic pathways. Pharmacogenomic studies also play a role by identifying genetic variations that affect individual responses to drugs and potential interactions.
